Home › Compare › SRBCF vs EQR

SRBCF vs EQR: Dividend Comparison 2026

SRBCF yields 39215.69% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SRBCF wins by $4.252735580217355e+22M in total portfolio value
10 years
SRBCF
SRBCF
● Live price
39215.69%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.252735580217355e+22M
Annual income
$42,315,093,309,418,040,000,000,000,000.00
Full SRBCF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — SRBCF vs EQR

📍 SRBCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSRBCFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SRBCF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SRBCF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SRBCF
Annual income on $10K today (after 15% tax)
$3,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$35,967,829,313,005,333,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, SRBCF beats the other by $35,967,829,313,005,333,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SRBCF + EQR for your $10,000?

SRBCF: 50%EQR: 50%
100% EQR50/50100% SRBCF
Portfolio after 10yr
$2.1263677901086776e+22M
Annual income
$21,157,546,654,709,020,000,000,000,000.00/yr
Blended yield
99.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

SRBCF
No analyst data
Altman Z
-90.9
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SRBCF buys
0
EQR buys
0
No recent congressional trades found for SRBCF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSRBCFEQR
Forward yield39215.69% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$4.252735580217355e+22M$47.8K ✓
Annual income after 10y$42,315,093,309,418,040,000,000,000,000.00 ✓$5,475.61
Total dividends collected$4.251340866571809e+22M$23.0K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: SRBCF vs EQR ($10,000, DRIP)

YearSRBCF PortfolioSRBCF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$3,932,269$3,921,568.63$11,380$679.82+$3.92M → SRBCF
2$1,445,390,825$1,441,183,297.58$13,014$837.25+$1445.38M → SRBCF
3$496,629,048,205$495,082,480,022.34$14,961$1,036.20+$496629.03M → SRBCF
4$159,510,701,964,776$158,979,308,883,196.16$17,297$1,289.22+$159510701.95M → SRBCF
5$47,892,225,784,148,210$47,721,549,333,045,900.00$20,121$1,613.15+$47892225784.13M → SRBCF
6$13,442,027,069,357,296,000$13,390,782,387,768,257,000.00$23,561$2,030.84+$13442027069357.27M → SRBCF
7$3,526,928,149,355,307,700,000$3,512,545,180,391,095,400,000.00$27,783$2,573.54+$3526928149355307.50M → SRBCF
8$865,104,634,553,737,800,000,000$861,330,821,433,927,700,000,000.00$33,013$3,284.39+$865104634553737856.00M → SRBCF
9$198,376,161,453,751,100,000,000,000$197,450,499,494,778,630,000,000,000.00$39,547$4,223.51+$198376161453751107584.00M → SRBCF
10$42,527,355,802,173,560,000,000,000,000$42,315,093,309,418,040,000,000,000,000.00$47,791$5,475.61+$4.252735580217355e+22M → SRBCF

SRBCF vs EQR: Complete Analysis 2026

SRBCF — Stock

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. Sirona Biochem Corp. has a research collaboration agreement with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop antiviral library of compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

Full SRBCF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this SRBCF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SRBCF vs SCHDSRBCF vs JEPISRBCF vs OSRBCF vs KOSRBCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.